Having trouble viewing this email? View it as a Web page.
What’s New at CBER
You are subscribed to What’s New at CBER for the U.S. Food & Drug Administration (FDA).
This page has been updated recently.
- User Fee Billable Biologic Products and Potencies Approved Under Section 351 of the PHS Act